NCT07424053

Brief Summary

The null hypothesis of the current study suggested that there will be no significant difference regarding the effect of Graphene Oxide (GO), Lesion sterilization and tissue repair (LSTR) and Zinc Oxide and Eugenol on the clinical and radiographic success rate of non-vital pulpotomy of primary teeth and that there will be no significant difference regarding the effect of Graphene Oxide (GO), MTA and Zinc Oxide and Eugenol on the clinical and radiographic success rate of vital pulpotomy of primary teeth. The children (n=126) will be divided randomly into 2 arms; each arm has 3 groups, according to the type of pulp therapy dressing, medicament,t and technique of its application as follows: First Arm (Vital Teeth) Group 1: will receive Graphene Oxide using the vital pulpotomy technique (study group, n=21) Group 2: will receive MTA using vital pulpotomy technique (study group, n=21) Group 3: will receive Zinc Oxide and Eugenol using the vital pulpotomy technique (control group, n=21) Second Arm (Non-Vital Teeth) Group A: will receive Graphene Oxide using the non-vital pulpotomy technique (study group, n=21). Group B: will receive LSTR using the non-vital pulpotomy technique (study group, n=21). Group C: will receive Zinc Oxide and Eugenol using non-vital pulpotomy (Control group, n=21). Clinical and radiographic success will be assessed as primary outcomes, while pain, patient satisfaction,n and time of procedure will be assessed as secondary outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Apr 2026Dec 2026

First Submitted

Initial submission to the registry

January 3, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

January 3, 2026

Last Update Submit

February 19, 2026

Conditions

Keywords

LSTRMTAZinc Oxide and EugenolGraphene OxideVital pulpotomyNon Vital PulpotomyPrimary teethConventional Pulp therapy techniques

Outcome Measures

Primary Outcomes (2)

  • Clinical success

    Assessing mobility, normal functioning, sensitivity to percussion, gingival inflammation, periodontal pocket formation, and presence or absence of sinus tract according to a scoring system from (1) to (4) as follows: Score (1): Asymptomatic Pathology: absent Normal functioning Mobility: (physiological) ≤ 1mm Score (2): Slight Discomfort, short-lived Pathology: questionable Percussion sensitivity Gingival inflammation: (due to poor oral hygiene) Mobility: (physiological) ≤ 1mm Score (3): Minor discomfort, short-lived Pathology: initial changes present Gingival swelling: (not due to poor oral hygiene) Mobility: \> 2 mm but \< 3 mm Score (4): Major discomfort, long-lived. Extract immediately Pathology: Late changes present Spontaneous pain Gingival swelling: (not due to poor oral hygiene) Periodontal pocket formation (exudate) Sinus tract present Mobility: ≤ 3mm Premature tooth loss due to pathology

    Immediate Postoperative, 1 week, 3 months, 6 months and 12 months

  • Radiographic success

    Radiographic evaluation will be assessed using a scoring system from score (1) to (4) as follows: Score (1): No changes at 6 months follow-up\* Internal root canal tapering from the chamber to the apex Periodontal ligament \\ periapical regions; normal width and trabeculation Score (2): Questionable Pathological changes at 3 months follow-up\* No External changes (widened PDL), abnormal inter-radicular trabeculation, or variation in radiodensity Internal resorption is acceptable (not perforated) Calcific metamorphosis is acceptable Score (3): Pathological changes present at 1-month follow-up\* External changes are present, but not large Mildly widened PDL Minor inter-radicular radiolucency with trabeculation still present Minor external root resorption; internal resorption changes are acceptable, but not if external changes are also present (perforated form) Score (4): Pathological changes are present. Extract immediately Frank osseous radiolucency present

    Immediate Postoperative, 3 months, 6 months and 12 months

Secondary Outcomes (3)

  • Presence or absence of pain

    Immediate Postoperative

  • Patient satisfaction

    Immediate Postoperative

  • Time of procedure

    Immediate Postopertive

Study Arms (6)

Group 1: will receive Graphene Oxide using vital pulpotomy technique

EXPERIMENTAL

Group 1: Vital Teeth will receive Graphene Oxide using vital pulpotomy technique (study group, n=21)

Other: Graphene Oxide using vital pulpotomy technique

Group 2: MTA using vital pulpotomy technique

EXPERIMENTAL

Group 2: will receive MTA using vital pulpotomy technique (study group, n=21)

Other: MTA using vital pulpotomy technique

Group 3: will receive Zinc Oxide and Eugenol using vital pulpotomy technique (control group, n=21)

ACTIVE COMPARATOR

Group 3: will receive Zinc Oxide and Eugenol using vital pulpotomy technique (control group, n=21)

Other: Zinc Oxide and Eugenol using vital pulpotomy technique

Group a: will receive Graphene Oxide using non-vital pulpotomy technique (study group, n=21).

EXPERIMENTAL

Group a: will receive Graphene Oxide using non-vital pulpotomy technique (study group, n=21).

Other: Graphene Oxide using non-vital pulpotomy technique

Group b: will receive LSTR using non-vital pulpotomy technique (study group, n=21).

EXPERIMENTAL

Group b: will receive LSTR using non-vital pulpotomy technique (study group, n=21).

Other: LSTR using non-vital pulpotomy technique

Group c: will receive Zinc Oxide and Eugenol using non-vital pulpotomy (Control group, n=21)

ACTIVE COMPARATOR

Group c: will receive Zinc Oxide and Eugenol using non-vital pulpotomy (Control group, n=21).

Other: Zinc Oxide and Eugenol using non-vital pulpotomy

Interventions

After administering local anesthesia, the tooth will be isolated with a rubber dam. All caries will be removed, and coronal access will be gained using a sterile No. 330 bur mounted on a water-cooled high-speed turbine to expose the pulp chamber. A spoon excavator will be used for coronal pulp amputation. The pulp chamber will then be irrigated with saline solution to remove all debris. Hemostasis will be obtained with a moistened cotton pellet gently pressed against the amputated pulp stumps in both groups. Hemorrhage should stop within 5 min of applying the cotton pellet. Graphene Oxide will be applied to cover the pulp chamber. will be prepared as per the manufacturer's instructions to obtain a putty-like consistency. The mixture will be delivered to the pulp stumps and condensed lightly with a moistened sterile cotton pellet. A thick mix of the material will be applied Teeth of all tested groups will be restored after the pulp therapy using high-viscosity glass ionomer

Group 1: will receive Graphene Oxide using vital pulpotomy technique

After administering local anesthesia, the tooth will be isolated with a rubber dam. All caries will be removed, and coronal access will be gained using a sterile No. 330 bur mounted on a water-cooled high-speed turbine to expose the pulp chamber. A spoon excavator will be used for coronal pulp amputation. The pulp chamber will then be irrigated with saline solution to remove all debris. Hemostasis will be obtained with a moistened cotton pellet gently pressed against the amputated pulp stumps in both groups. Hemorrhage should stop within 5 min of applying the cotton pellet. MTA will be applied to cover the pulp chamber. will be prepared as per the manufacturer's instructions to obtain a putty-like consistency. The mixture will be delivered to the pulp stumps and condensed lightly with a moistened sterile cotton pellet. A thick mix of the material will be applied Teeth of all tested groups will be restored after the pulp therapy using high-viscosity glass ionomer

Group 2: MTA using vital pulpotomy technique

After administering local anesthesia, the tooth will be isolated with a rubber dam. All caries will be removed, and coronal access will be gained using a sterile No. 330 bur will be mounted on a water-cooled high-speed turbine to expose the pulp chamber. A spoon excavator will be used for coronal pulp amputation. The chamber will then be irrigated with saline solution to remove all debris. Hemostasis will be obtained with a moistened cotton pellet gently pressed against the amputated pulp stumps in both groups. Hemorrhage should stop within 5 min of applying the cotton pellet. Zinc oxide Eugenol will be applied to cover the pulp chamber. will be prepared as per the manufacturer's instructions to obtain a putty-like consistency. The mixture will be delivered to the pulp stumps and condensed lightly with a moistened sterile cotton pellet. A thick mix of the material will be applied Teeth of all tested groups will be restored after the pulp therapy using high-viscosity glass ionomer

Group 3: will receive Zinc Oxide and Eugenol using vital pulpotomy technique (control group, n=21)

Absolute isolation with a rubber dam. Decayed dentin will be removed using spoon-shaped dentin excavators. The pulp chamber roof will be removed with a high-speed sterile carbide bur number 330, followed by irrigating the pulp chamber with two percent chlorhexidine solution and drying it with cotton balls. After these steps, a non-vital pulpotomy will be performed The coronal parts will be restored by preformed stainless steel crowns.

Group a: will receive Graphene Oxide using non-vital pulpotomy technique (study group, n=21).

Absolute isolation with a rubber dam. Decayed dentin will be removed using spoon-shaped dentin excavators. The pulp chamber roof will be removed with a high-speed sterile carbide bur number 330, followed by irrigating the pulp chamber with two percent chlorhexidine solution and drying it with cotton balls. After these steps, a non-vital pulpotomy will be performed The coronal parts will be restored by preformed stainless steel crowns.

Group b: will receive LSTR using non-vital pulpotomy technique (study group, n=21).

Absolute isolation with a rubber dam. Decayed dentin will be removed using spoon-shaped dentin excavators. The pulp chamber roof will be removed with a high-speed sterile carbide bur number 330, followed by irrigating the pulp chamber with two percent chlorhexidine solution and drying it with cotton balls. After these steps, a non-vital pulpotomy will be performed The coronal parts will be restored by preformed stainless steel crowns.

Group c: will receive Zinc Oxide and Eugenol using non-vital pulpotomy (Control group, n=21)

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Cooperative child
  • Presence of symptom-free deep carious lesions
  • Presence of at least two-thirds of the root length radiographically; restorable tooth
  • (Second Arm)
  • Primary teeth diagnosed with pulp necrosis, root resorption equal to or less than one-third (with sufficient dental structure for absolute isolation with rubber dam)
  • History of spontaneous pain and mobility incompatible with chronological age, possibly with the presence of a sinus tract or swelling
  • Presence or absence of a radiolucent area in the periapical or furcation region

You may not qualify if:

  • History of systemic diseases
  • Teeth showing clinical and radiographical evidence of pulp degeneration, such as history of spontaneous or nocturnal pain, tenderness to percussion or palpation, pathologic mobility, swelling or fistulous tract, periodontal ligament (PDL) space widening, internal root resorption, external root resorption, furcal radiolucency/inter-radicular bone destruction, and/or periapical bone destruction
  • Teeth without a permanent successor
  • Teeth requiring more than 5 minutes to achieve hemostasis during the clinical procedure
  • (Second Arm)
  • Children with a history of allergic reaction to the components of the tested materials
  • Children had used antibiotics in the last three months.
  • Teeth with pulp canal obliteration or internal or external pathological root resorption visible in periapical radiographs
  • Coronal destruction that would prevent absolute isolation with a rubber dam and/or restoration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Zinc Oxide

Intervention Hierarchy (Ancestors)

OxidesOxygen CompoundsInorganic ChemicalsZinc Compounds

Central Study Contacts

Mennah Helal, Master of science

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will involve children aged between 5 and 10 years old with primary teeth indicated for pulp therapy Subject grouping: The involved children (n=126) will be divided randomly into 2 arms; each arm has 3 groups, according to the type of pulp therapy dressing medicament and technique of its application, as follows: First Arm (Vital Teeth) Group 1: will receive Graphene Oxide using the vital pulpotomy technique (study group, n=21) Group 2: will receive MTA using vital pulpotomy technique (study group, n=21) Group 3: will receive Zinc Oxide and Eugenol using the vital pulpotomy technique (control group, n=21) Second Arm (Non-Vital Teeth) Group A: will receive Graphene Oxide using the non-vital pulpotomy technique (study group, n=21). Group B: will receive LSTR using the non-vital pulpotomy technique (study group, n=21). Group C: will receive Zinc Oxide and Eugenol using non-vital pulpotomy (Control group, n=21).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD Candidate, Pediatric Dentistry Department, Azhar University

Study Record Dates

First Submitted

January 3, 2026

First Posted

February 20, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 20, 2026

Record last verified: 2026-02